• Hero Banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Buying or Selling a Practice
Hospital Design
Leadership & Personal Growth
Personnel Management
Practice Finances
Practice Operations
Technology
Wellbeing & Lifestyle
Continuing Education
Conferences
Live Conferences
Conference News
Conference Proceedings
Resources
CBD in Pets
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Extraocular myositis in a young pit bull

August 3, 2021
Amanda Joslin, DVM, DACVO
dvm360, dvm360 August 2021, Volume 52,

The owners opted to forgo diagnostic testing but accepted treatment of the presumptive diagnosis.

Patient presentation

History

A 32-kg spayed pit bull age 14 months was presented April 21, 2020, to the Mount Laurel Animal Hospital primary care service in New Jersey for evaluation of intermittently bulging eyes, yawning, and refusing hard treats. On presentation, the patient was friendly but nervous. A comprehensive physical examination was attempted, but the dog was resistant to both a rectal and an oral examination. Abnormalities identified on physical examination included a class III malocclusion and ocular changes.

An in-house ophthalmic consultation and examination revealed exophthalmos affecting both eyes, with no protrusion of the third eyelid and moderate conjunctival hyperemia Figure 1). The dog was exhibiting no visual deficits. The left eye had a focal, triangular, temporal, anterior cortical cataract. The patient exhibited no obvious discomfort on palpation of the masticatory muscles bilaterally and no restriction of jaw mobility.

Diagnostics

Advertisement
  • Serologic testing for masticatory muscle myositis, neosporosis, toxoplasmosis, and Lyme borreliosis was recommended but declined by the owners.
  • Ophthalmic diagnostics were normal, including absent fluorescein stain uptake and a normal intraocular pressure bilaterally.

Summary

In summary, this patient was a young, large-breed dog with nonpainful exophthalmos. There was no change in positioning of the nictitating membrane bilaterally, no visual deficits, no systemic signs, and no comorbidities on presentation.

Treatment

After discussion with the owners emphasizing presumptive extraocular myositis based on presenting signalment, clinical signs, and examination findings, they elected to pursue empiric treatment.

  • A slowly tapering course of oral immunosuppressive steroids was started at 2 mg/kg divided into twice-daily administration.
  • A 3-week course of twice-daily oral doxycycline at 5 mg/kg was also prescribed to cover for potential infections.
  • A recheck examination with the ophthalmology service 2 weeks after treatment started was recommended.

Ten days after initial presentation, the client called with an update, reporting that the dog’s eyes were back to normal but the dog was experiencing significant adverse effects (AEs), including a ravenous appetite and increased water consumption.

  • Oral prednisone was tapered to 1 mg/kg divided into twice-daily administration.
  • A second update 8 days later (ie, 18 days after initial presentation) revealed worsening of the steroidal AEs, including persistent ravenous appetite, significant loss of muscle mass, urinary accidents in the house, lethargy, and panting most notable at night.
  • The dose of oral prednisone was tapered to ≈0.6 mg/kg, still divided into twice-daily administration.
  • A recheck examination was recommended for the following day.

Outcome

  • Three weeks after initial presentation (ie, a few days after the client’s second report), the patient was returned for a recheck evaluation (Figure 2).
  • The dog had lost 2.2 kg over the course of treatment and had moderate muscle wasting.
  • Her eyes had returned to a normal position, with no apparent permanent changes affecting either eye.
  • Because of the significant steroidal AEs, prednisone was tapered and ended over the following 2 weeks.
  • A 1-year follow-up was recommended to monitor progression of the cataract.

Discussion

Extraocular myositis is a focal inflammatory myopathy observed most in young, predominantly large- or giant-breed dogs.1-3 The typical presenting signs are exophthalmos without protrusion of the nictitating membrane and congestion of the episcleral vessels.1-3

  • If advanced imaging is pursued— including ultrasonography, CT, or MRI—it would reveal swollen extraocular muscles.1
  • Histopathology of the inflamed muscles would reveal CD3+ lymphocytes and macrophages as the predominant cell types.1-3
  • Most patients respond well to a course of immunosuppressive steroids administered over 3 to 4 weeks.1
  • In patients with chronic inflammation, detrimental AEs can develop, and in patients with uncontrolled or chronic inflammation, fibrosis of the extraocular muscles can result in enophthalmos with strabismus.2,3
  • If the changes are severe, a corrective procedure may be required to reposition the eye.2,3
  • While the appearance is similar to Graves syndrome in humans, extraocular myositis has no known association with hypothyroidism or hyperthyroidism.1

Diagnostic testing was recommended because of the varied differential diagnoses, but the owners elected to treat with the presumptive diagnosis of extraocular myositis. Although considering differential diagnoses, masticatory muscle myositis is also a focal inflammatory myopathy, but there are typically a few differences when these patients present clinically for ophthalmic and physical examinations.2,3 Masticatory muscle myositis also results in exophthalmos, but the third eyelid is typically elevated from swelling of the pterygoid muscle.1-3

  • On physical examination, these dogs are predominantly young to middle-age large-breed dogs that present with fever, lethargy, weight loss, potential blindness, and restricted jaw movement from swelling of the masseter, temporal, and pterygoid muscles.1-3
  • The masticatory muscles affected all contain type 2M myofibers, which can be identified with serology, allowing for diagnosis.1
  • If the dogs present blind with this disease, it is from compression or tension on the optic nerve.1-3
  • Other infectious causes that should be ruled out based on location are neosporosis, toxoplasmosis, leishmaniasis, and Lyme borreliosis.1

References

  1. Spiess BM, Pot SA. Diseases and surgery of the canine orbit. In: Gellatt KN, Gilgerl BC, Kern TK, eds. Veterinary Ophthalmology. 5th ed. WileyBlackwell; 2013:808-810.
  2. Webb AA, Cullen CL. Neuroophthalmology. In: Gellatt KN, Gilgerl BC, Kern TK, eds. Veterinary Ophthalmology. 5th ed. WileyBlackwell; 2013:1862-1863.
  3. Cullen CL, Webb AA. Ocular manifestations of systemic disease part 1: the dog. In: Gellatt KN, Gilgerl BC, Kern TK, eds. Veterinary Ophthalmology. 5th ed. Wiley-Blackwell; 2013:1916-1917.

download issueDownload Issue: dvm360 August 2021

Related Content:

RolesTechniciansAssociatesClinicalOphthalmologydvm360 August 2021
Alternate therapies for pain management
Alternate therapies for pain management
Diagnostics for a thoracic trauma patient
Diagnostics for a thoracic trauma patient
Managing pain in the postoperative patient
Managing pain in the postoperative patient

Advertisement

Latest News

Drug for acute onset of canine pancreatitis is launched on the US market

New Automatic 2-in-1 Pet Feeder and Water Dispenser launched

PetHub launches AI tools for pet owners

Prairie dog pups emerge from underground at Maryland Zoo

View More Latest News
Advertisement